Magnetic resonance spectroscopy in the diagnostic evaluation of brainstem lesions in Alexander disease

Journal of Child Neurology

Volumn 26, Issue 3, 2011, Pages 356-360

  Davison, James E ^a,b   Davies, Nigel P ^a,c   English, Martin W ^a   Philip, Sunny ^a   MacPherson, Lesley K R ^a   Gissen, Paul ^a,b   Peet, Andrew C ^a,b  

^a BIRMINGHAM CHILDREN S HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Alexander disease; brain tumors; brainstem; gliomas; magnetic resonance spectroscopy; radiology

Indexed keywords

ALEXANDER DISEASE; ARTICLE; BRAIN STEM TUMOR; CANCER GRADING; CASE REPORT; CHILD; DIFFERENTIAL DIAGNOSIS; FEMALE; GLIOMA; HUMAN; METABOLITE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRESCHOOL CHILD; PRIORITY JOURNAL;

ALEXANDER DISEASE; BRAIN STEM; CHILD; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY;

EID: 79952671831     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073810381279     Document Type: Article

References (20)

1. Van Poppel K, Broniscer A, Patay Z, Morris EB. Alexander disease: an important mimicker of focal brainstem glioma. Pediatr Blood Cancer. 2009;53:1355-1356.
2. Ring S, Lackner H, Urban C, et al. Alexander disease: an important mimicker of focal brainstem glioma. Pediatr Blood Cancer. 2010;54:486.
3. Quinlan RA, Brenner M, Goldman JE, et al. GFAP and its role in Alexander disease. Exp Cell Res. 2007;313:2077-2087. (Pubitemid 46842983)
4. Van der Knaap MS, Valk J. Alexander disease. In: Van der Knaap MS, Valk J, eds. Magnetic Resonance of Myelination and Myelin Disorders. New York, NY: Springer; 2005:416-435.
5. Van der Knaap MS, Naidu S, Breiter SN, et al. Alexander disease: diagnosis with MR imaging. AJNR Am J Neuroradiol. 2001;22: 541-552. (Pubitemid 32221425)
6. Bassuk AG, Joshi A, Burton BK, et al. Alexander disease with serial MRS and a new mutation in the glial fibrillary acidic protein gene. Neurology. 2003;61:1014-1015. (Pubitemid 37248672)
7. Brockmann K, Dechent P, Meins M, et al. Cerebral proton magnetic resonance spectroscopy in infantile Alexander disease. J Neurol. 2003;250:300-306. (Pubitemid 36399269)
8. Imamura A, Orii KE, Mizuno S, et al. MR imaging and 1H-MR spectroscopy in a case of juvenile Alexander disease. Brain Dev. 2002;24:723-726. (Pubitemid 35300324)
9. Van der Voorn JP, Pouwels PJ, Salomons GS, et al. Unraveling pathology in juvenile Alexander disease: serial quantitative MR imaging and spectroscopy of white matter. Neuroradiology. 2009;51:669-675.
10. Mignot C, Desguerre I, Burglen L, et al. Tumor-like enlargement of the optic chiasm in an infant with Alexander disease. Brain Dev. 2009;31:244-247.
11. Duckett S, Schwartzman RJ, Osterholm J, et al. Biopsy diagnosis of familial Alexander's disease. Pediatr Neurosurg. 1992;18: 134-138.
12. Van der Knaap MS, Salomons GS, Li R, et al. Unusual variants of Alexander's disease. Ann Neurol. 2005;57:327-338. (Pubitemid 40343954)
13. Peet AC, Arvanitis TN, Auer DP, et al. The value of magnetic resonance spectroscopy in tumour imaging. Arch Dis Child. 2008;93:725-727.
14. Harris LM, Davies N, Macpherson L, et al. The use of shortecho-time 1H MRS for childhood cerebellar tumours prior to histopathological diagnosis. Pediatr Radiol. 2007;37: 1101-1109. (Pubitemid 47561840)
15. Busch V, Freisinger P, Rudisser K, et al. Atypical variant of Alexander's disease with involvement of the spinal cord. Neuropediatrics. 2006;37:v1112.
16. Provencher SW. Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed. 2001;14:260-264. (Pubitemid 32611437)
17. Davies NP, Wilson M, Harris LM, et al. Identification and characterisation of childhood cerebellar tumours by in vivo proton MRS. NMR Biomed. 2008;21:908-918.
18. Fisher SK, Novak JE, Agranoff BW. Inositol and higher inositol phosphates in neural tissues: homeostasis, metabolism and functional significance. J Neurochem. 2002;82: 736-754.
19. Fenili D, Brown M, Rappaport R, McLaurin J. Properties of scyllo-inositol as a therapeutic treatment of AD-like pathology. J Mo Med. 2007;85:603-611. (Pubitemid 46870891)
20. Griffith HR, den Hollander JA, Stewart CC, et al. Elevated brain scyllo-inositol concentrations in patients with Alzheimer's disease. NMR Biomed. 2007;20:709-716. (Pubitemid 350300974)